Loading...
XSHE
300132
Market cap536mUSD
Dec 05, Last price  
7.61CNY
1D
4.10%
1Q
15.13%
Jan 2017
-27.36%
IPO
-21.93%
Name

Fujian Green Pine Co Ltd

Chart & Performance

D1W1MN
XSHE:300132 chart
P/E
69.39
P/S
1.96
EPS
0.11
Div Yield, %
—
Shrs. gr., 5y
1.28%
Rev. gr., 5y
-7.78%
Revenues
1.94b
-1.51%
152,526,566225,859,525294,408,805486,369,993550,401,913554,618,362632,142,164763,215,975588,960,344557,290,828811,205,1431,421,571,0692,908,117,1243,864,762,2143,693,254,6732,917,366,4761,969,494,7171,939,766,368
Net income
55m
P
14,892,72418,678,18127,625,92642,411,66221,171,93231,829,64828,677,51652,210,43610,900,38832,734,60194,745,969400,352,718453,164,927460,795,67500-68,341,30954,683,418
CFO
179m
+14.40%
5,208,06815,525,592005,239,437045,019,12470,477,10199,594,74574,670,682045,427,619676,232,559805,835,59844,195,785340,636,749156,604,754179,160,393
Dividend
Jun 11, 20210.18 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Fujian Green Pine Co., Ltd. engages in the research, development, production, and sale of turpentine derivatives. The company offers synthetic camphor, isobornyl acetate, camphene, borneol flakes, para cymene, pinene, dipentene, isoborneol, crystalline sodium acetate, anhydrous sodium acetate, isobornyl (meth) acrylate, myrcene, benzyl acetate, QS keton, and solvent oils for applications in flavors, fragrances, pharmaceutical and personal care products, cleaning supplies, painting and coating fields, etc. It has operations in Asia, Europe, North America, South America, Oceania, and Africa. The company was formerly known as Jianyang City Green Pine Chemical Co., Ltd. and changed its name to Fujian Green Pine Co., Ltd. in May 2009. Fujian Green Pine Co., Ltd. was founded in 1958 and is headquartered in Jianyang, China.
URL
http://www.greenpine.cc/
IPO date
Oct 26, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT